Kezar Life Sciences Inc (KZR)

4.990
-0.030(-0.60%)
After Hours
5.010
+0.020(+0.401%)
- Real-time Data
  • Volume:
    962,432
  • Day's Range:
    4.990 - 5.210
  • 52 wk Range:
    4.610 - 18.550

KZR Overview

Prev. Close
5.02
Day's Range
4.99-5.21
Revenue
-
Open
5
52 wk Range
4.61-18.55
EPS
-1.05
Volume
962,432
Market Cap
303.29M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,066,990
P/E Ratio
-
Beta
0.7
1-Year Change
-12.15%
Shares Outstanding
60,415,586
Next Earnings Date
Aug 10, 2022
What is your sentiment on Kezar Life?
or
Market is currently closed. Voting is open during market hours.

Kezar Life Sciences Inc News

Kezar Life Sciences Inc Analysis

Kezar Life Sciences Inc Company Profile

Kezar Life Sciences Inc Company Profile

Employees
47

Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company’s lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical trials for various indications, including lupus nephritis, dermatomyositis, and polymyositis; and Phase 1b clinical trials in systemic lupus erythematosus and lupus nephritis. Its preclinical products include KZR-261, a novel first-in-class protein secretion inhibitor for the treatment of KZR-261; and KZR-TBD for the treatment of oncology and immunology. The company was incorporated in 2015 and is based in South San Francisco, California.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellSell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
  • quien jala a invertir
    0
    • DE HUEVOS
      0